Skip to the page

Data / Form D filings / Pictura Bio US, Inc.

Pictura Bio US, Inc.: Form D filings

Pictura Bio US, Inc., a biotechnology company in Oxford, United Kingdom, filed 2 Form D notices with the SEC in 2026. The latest, on September 28, 2026, reports $9.1 million sold of a $17.5 million offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
WOOD CENTRE FOR INNOVATION QUARRY ROAD, HEADINGTON, Oxford, United Kingdom, OX3 8
Phone
(760) 523-0047
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2026
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2152538

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 28, 2026New notice$17,460,598$9,125,915$8,334,6836Aug 14, 2026sec.gov
Sep 28, 2026New notice$15,000,000$15,000,00020Aug 12, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Alex WilsonDirector
Nicole RobbDirector
Cary GunnExecutive Officer, Director
Steven PowellDirector

Every Form D from the week of Sep 28, 2026 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Pictura Bio US, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.